SHG:688399 - Jiangsu Bioperfectus Technologies Co Ltd

Jiangsu Bioperfectus Technolog
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2016 Q4	2017 Q4	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.3B -4.1%	2.81B 22.3%	2.84B 1.0%	3.5B 23.4%	4.97B 41.9%	4.96B -0.3%	5.53B 11.6%	4.11B -25.8%	2.46B -40.2%	1.52B -38.2%	403.18M -73.4%	400.25M -0.7%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	595.49M 0.6%	794.36M 33.4%	876.35M 10.3%	1.2B 37.0%	1.87B 56.0%	1.95B 4.3%	2.18B 11.6%	1.66B -23.7%	952.09M -42.7%	601.14M -36.9%	145.5M -75.8%	139.26M -4.3%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.7B -5.6%	2.02B 18.5%	1.96B -2.7%	2.3B 17.4%	3.1B 34.6%	3.01B -3.0%	3.35B 11.6%	2.44B -27.1%	1.5B -38.5%	916.59M -39.0%	257.68M -71.9%	260.98M 1.3%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.13B 1.7%	1.38B 21.8%	1.48B 7.4%	1.86B 25.4%	2.73B 46.8%	2.81B 3.2%	3.07B 9.2%	2.42B -21.3%	1.52B -37.1%	1.16B -23.6%	617.68M -46.8%	563.28M -8.8%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	536.6M 3.0%	584.52M 8.9%	604.79M 3.5%	656.49M 8.5%	854.11M 30.1%	861.37M 0.8%	894.58M 3.9%	756.42M -15.4%	569.9M -24.7%	560.98M -1.6%	472.18M -15.8%	424.02M -10.2%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.17B -9.1%	1.43B 22.9%	1.36B -5.2%	1.65B 21.3%	2.25B 36.4%	2.15B -4.5%	2.46B 14.6%	1.69B -31.4%	933.47M -44.7%	355.61M -61.9%	-214.5M -	-163.04M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.01B -	-	1.19B -	-	1.92B -	-	1.83B -	-	526.08M -	-	-373.81M -	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.01B -8.1%	1.23B 21.7%	1.19B -3.3%	1.44B 20.4%	1.92B 33.9%	1.82B -5.4%	1.83B 0.4%	1.18B -35.6%	526.08M -55.3%	27.53M -94.8%	-373.81M -	-314.32M -
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	17.29 -8.1%	21.04 21.7%	20.36 -3.2%	24.52 20.4%	32.84 33.9%	31.08 -5.4%	31.18 0.3%	20.08 -35.6%	8.97 -55.3%	0.47 -94.8%	-6.38 -	-5.37 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	17.29 -8.1%	21.04 21.7%	20.36 -3.2%	24.52 20.4%	32.84 33.9%	31.08 -5.4%	31.18 0.3%	20.08 -35.6%	8.97 -55.3%	0.47 -94.8%	-6.38 -	-5.37 -